$ANTX Balance Sheet | Understand Stock

$ANTX

$3.50 -$0.13 (3.58%) After hours

$ANTX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022
Assets
Current assets:
Cash and cash equivalents
Short-term investments
Prepaid expenses and other current assets
Right-of-use asset, net
Total current assets

Deferred offering costs
Long-term investments
Other assets, long-term
Total assets

Liabilities and stockholders' equity
Current liabilities:
Accounts payable
Accrued compensation
Accrued liabilities
Other current liabilities
Operating lease liabilities
Options subject to repurchase, short-term
Total current liabilities

Options subject to repurchase, long-term
Other non-current liabilities
Total liabilities
Redeemable convertible preferred stock: $0.00001 par value; 0 and 11,409,536 shares authorized at September 30, 2022 and December 31, 2021, respectively, 0 and 11,409,488 shares issued and outstanding at September 30, 2022 and December 31, 2021; aggregate liquidation preference $0 and $103,064 at September 30, 2022 and December 31, 2021, respectively
Stockholders' equity:
Additional paid-in capital
Accumulated other comprehensive (loss) gain
Accumulated deficit
Total stockholders' equity
Total liabilities and stockholders' equity

Comments